Under the Microscope: OCRF’s 2012 Research Progress Report
12/11/12 | In 2012, hardworking, dedicated OCRF scientists made significant advances in the fight against ovarian cancer. Below is just a sample of some of the exciting discoveries made by OCRF-funded researchers this year.
With your generous support, OCRF grantees have:
- Explained reduced survival and high platelets in ovarian cancer patients
- Provided further evidence that ovarian cancer begins in the fallopian tube
- Defined the association between endometriosis and ovarian cancer
- Discovered that AKT inhibition may be an effective treatment strategy for some patients
- Shown that patients with good social support live longer
- Demonstrated that targeting the NOTCH pathway helps overcome platinum drug resistance
- Found that microRNAs convert normal cells into cancer promoters
- Discovered that a common diabetes drug may boost ovarian cancer survival
Thank you for supporting our mission to fund scientific research that will lead to more effective identification, treatment, and ultimately a cure for this terrible disease.
With each new finding, we are one step closer to changing the future of ovarian cancer.
To read more about clinical advancements and scientific breakthroughs from OCRF-funded researchers, please view our new Progress: The Science of Hope Brochure.
Stay tuned next month for our 2013 research grant awards announcement!